Jo-Anne H. Young American physician
Young, Jo-Anne H.
VIAF ID: 4102156223656005400001 (Personal)
Permalink: http://viaf.org/viaf/4102156223656005400001
Preferred Forms
-
100 0 _
‡a
Jo-Anne H. Young
‡c
American physician
-
100 1 _
‡a
Young, Jo-Anne H.
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases |
|
| Acknowledgment of Reviewers |
|
| Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research |
|
| The ASM Journals Committee Values the Contributions of Black Microbiologists |
|
| ASM Journals Eliminate Impact Factor Information from Journal Websites |
|
| Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance |
|
| Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. |
|
| Dasatinib-induced immunosuppression and recurrent respiratory tract infections |
|
| Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection |
|
| Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma |
|
| Genitourinary Tract Infection Due to Mycobacterium avium intracellulare Complex Infection in Pretransplant Setting With Recurrence Following Transplant: A Case Report |
|
| Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival |
|
| Histoplasmosis after solid organ transplant |
|
| Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? |
|
| Identification of Pathogenic Fungi |
|
| The impact of cytomegalovirus infection ≥1 year after primary renal transplantation |
|
| In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia |
|
| Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation |
|
| Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors |
|
| Infectious complications of acute and chronic GVHD. |
|
| Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. |
|
| Lethal small bowel necrosis due to aspergillosis during acute promyelocytic leukemia induction |
|
| Management of Infectious Diseases in Stem Cell Transplantation and Hematologic Malignancy |
|
| Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study |
|
| Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation |
|
| A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. |
|
| A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients |
|
| Pre-Transplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (E. Gallinarum and E. Casseliflavus) and Outcomes of Allogeneic Hematopoietic Cell Transplantation. |
|
| Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy |
|
| A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation |
|
| Recurrence of Clostridium difficile infection after total colectomy in an allogeneic stem cell transplant patient |
|
| Removal notice to (617) - Candida Colonization Is Associated with Improved Survival After Lung Transplant J Heart Lung Transplant 36 (2017) S238. |
|
| Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. |
|
| Time trends in fungal infections as a cause of death in hematopoietic stem cell transplant recipients: an autopsy study |
|
| Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens, but protect the indigenous microbiota. |
|
| Transformed large B-cell lymphoma in rituximab-allergic patient with chronic lymphocytic leukemia after allogeneic stem cell transplant: successful treatment with ofatumumab |
|
| Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America |
|
| Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial |
|
